Hospital Universitario Ramon y Cajal ( Site 1301)

Madrid 28034

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Renal Cell, Coronavirus Disease (COVID-19)

Studies at this site

• Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A) — Running, not enrolling
• Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) — Completed
• Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) — Stopped early